There are 1105 resources available
217P - The efficacy and safety of tislelizumab as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after radical reaction
Presenter: Ning Peng
Session: Poster Display session
Resources:
Abstract
218P - Clinical significance of tumor-associated high endothelial venules in hepatocellular carcinoma
Presenter: Shu Aoyama
Session: Poster Display session
Resources:
Abstract
219P - Can the blood coagulation factor, von Willebrand factor, be a predictor of response to atezolizumab plus bevacizumab combination therapy for advanced hepatocellular carcinoma?
Presenter: Hiroaki Takaya
Session: Poster Display session
Resources:
Abstract
220P - Outcomes with first-line therapy and impact of ALBI grade in advanced hepatocellular carcinoma: Insights from a lower-middle-income country
Presenter: Mohammad Naviwala
Session: Poster Display session
Resources:
Abstract
221P - Survival analysis of TACE monotherapy vs. combination therapy in BCLC B and C stage hepatocellular carcinoma: A retrospective cohort study
Presenter: Chengxiang Guo
Session: Poster Display session
Resources:
Abstract
222P - The activity and safety of icaritin for patients with unresectable hepatocellular carcinoma: A real-world, retrospective study
Presenter: Zeng Hui
Session: Poster Display session
Resources:
Abstract
223P - Hepatic artery infusion chemotherapy (HAIC) combined with camrelizumab and apatinib as conversion therapy for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial
Presenter: Xu Zhou
Session: Poster Display session
Resources:
Abstract
224P - Neoadjuvant therapy versus initial hepatectomy for resectable intermediate or advanced hepatocellular carcinoma (GUIDANCE002): A multicenter, retrospective cohort study
Presenter: Jian-Hong Zhong
Session: Poster Display session
Resources:
Abstract
225P - Real adjuvant transarterial chemoembolization is not associated with good survival in most patients with hepatocellular carcinoma: A multicenter retrospective study
Presenter: Jian-Rong Li
Session: Poster Display session
Resources:
Abstract
226P - Immune checkpoint inhibitor rechallenge in advanced hepatocellular carcinoma: A retrospective cohort study
Presenter: Jing-Kun Chen
Session: Poster Display session
Resources:
Abstract